<p>泰利福（NYSE:TFX - 获取免费报告）在周六发布的报告中被华尔街 Zen 的研究分析师从 “持有” 评级下调至 “卖出” 评级。</p>
<p>其他一些分析师最近也对 TFX 发表了看法。雷蒙德·詹姆斯金融公司在周五的研究报告中重申了 “跑赢大盘” 评级，并将泰利福的目标股价设定为 150.00 美元。韦斯评级在 3 月 27 日的研究报告中重申了泰利福的 “卖出（d）” 评级。加拿大皇家银行将泰利福的评级从 “行业表现” 上调至 “跑赢大盘”，并将其目标股价从 135.00 美元提高至 155.00 美元。瑞穗证券在周五为泰利福设定了 140.00 美元的目标股价。最后，美国银行在 4 月 13 日的研究报告中将泰利福的评级从 “表现不佳” 上调至 “中性”，并为该公司设定了 135.00 美元的目标股价。三位投资分析师对该股票给予了买入评级，五位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，泰利福目前的平均评级为 “持有”，平均目标股价为 142.86 美元。</p>
<p><strong>查看我们对 TFX 的最新分析</strong></p>
<h2>泰利福股票上涨 1.1%</h2>
<p>周五，泰利福股票开盘价为 133.17 美元。泰利福的 12 个月低点为 100.18 美元，12 个月高点为 139.67 美元。该股票的 50 日移动平均线为 119.44 美元，200 日移动平均线为 116.73 美元。公司的流动比率为 2.55，速动比率为 2.01，债务与股本比率为 0.82。该股票的市值为 58.9 亿美元，市盈率为-5.84，PEG 比率为 0.95，贝塔值为 0.82。</p>
<p>泰利福（NYSE:TFX - 获取免费报告）最后一次发布季度财报是在 5 月 7 日，医疗技术公司报告该季度每股收益为 1.39 美元，超出分析师一致预期的 1.21 美元，超出幅度为 0.18 美元。泰利福的股本回报率为 13.29%，净利润率为-35.88%。该公司在该季度的收入为 5.483 亿美元，而分析师预期为 5.3691 亿美元。去年同期，该公司每股收益为 1.44 美元。该公司的季度收入同比增长 32.3%。泰利福已将其 2026 财年的每股收益指引设定为 6.250-6.550 美元。整体来看，研究分析师预计泰利福在当前年度的每股收益将达到 6.75 美元。</p>
<h2>对泰利福的对冲基金看法</h2>
<p>一些大型投资者最近调整了对该公司的持股。Janus Henderson Group PLC 在第四季度将其在泰利福股票中的持股比例提高了 2.0%。Janus Henderson Group PLC 目前拥有 4,246,112 股医疗技术公司的股票，价值 518,196,000 美元，此前在上个季度又购买了 84,754 股。AQR 资本管理公司在第三季度将其在泰利福股票中的持股比例提高了 478.1%。AQR 资本管理公司目前拥有 2,366,131 股医疗技术公司的股票，价值 287,603,000 美元，此前在上个季度又购买了 1,956,811 股。道富银行在第四季度将其在泰利福股票中的持股比例提高了 1.5%。道富银行目前拥有 1,478,776 股医疗技术公司的股票，价值 180,470,000 美元，此前在上个季度又购买了 22,111 股。Dimensional Fund Advisors LP 在第四季度将其在泰利福股票中的持股比例提高了 0.4%。Dimensional Fund Advisors LP 目前拥有 1,250,665 股医疗技术公司的股票，价值 152,630,000 美元，此前在上个季度又购买了 5,051 股。最后，Cooke &amp; Bieler LP 在第三季度将其在泰利福股票中的持股比例提高了 1.2%。Cooke &amp; Bieler LP 目前拥有 1,220,637 股医疗技术公司的股票，价值 149,357,000 美元，此前在上个季度又购买了 14,673 股。95.62% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>影响泰利福的关键故事</h2>
<p>以下是本周影响泰利福的关键新闻：</p>
<ul>
<li>积极情绪：泰利福超出第一季度预期，报告调整后每股收益为 1.39 美元，而预期为 1.21 美元，收入为 5.483 亿美元，而预期为 5.369 亿美元，显示出该季度的稳健执行。文章标题</li>
<li>积极情绪：该公司维持其 2026 财年的整体展望，并宣布回购计划，这可以支持投资者信心和股价表现。文章标题</li>
<li>积极情绪：富国银行将 TFX 的目标股价从 130 美元上调至 138 美元，暗示当前水平有适度上行空间，并表明分析师情绪改善。文章标题</li>
<li>中性情绪：管理层的财报电话会议评论被描述为平衡，增长被利润率压力抵消，表明尽管财报超出预期，但业务仍在应对盈利压力。文章标题</li>
<li>消极情绪：泰利福更新的 2026 财年每股收益指引为 6.25 至 6.55 美元，低于市场预期的约 6.73 美元，尽管季度业绩超出预期，但可能限制热情。文章标题</li>
</ul>
<h2>关于泰利福</h2>
<p>（获取免费报告）</p>
<p>泰利福公司是一家多元化的全球医疗技术提供商，专注于危重护理和外科手术。公司总部位于宾夕法尼亚州韦恩，设计、制造和分销医疗专业人员在医院、门诊和其他场所使用的设备和解决方案。泰利福专注于提供支持复杂介入程序并改善患者结果的产品。</p>
<p>公司的产品涵盖多个关键领域，包括介入泌尿学、呼吸与麻醉、外科、心脏护理、血管和原始设备制造商（OEM）解决方案。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比泰利福更具吸引力</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRGWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRGWA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在 Teleflex 吗？</h2>
<p>在考虑 Teleflex 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛市场注意到之前购买的股票……而 Teleflex 并不在名单上。</p>
<p>虽然 Teleflex 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

泰利福

<p>华尔街禅将 Teleflex（纽约证券交易所代码：TFX）的评级从 “持有” 下调至 “卖出”。其他分析师的看法不一，Raymond James 维持 “跑赢大盘” 评级，目标价为 150 美元，而 Weiss Ratings 重申 “卖出” 评级。Teleflex 的股票开盘价为 133.17 美元，12 个月高点为 139.67 美元。该公司报告第一季度每股收益为 1.39 美元，超出预期，营收为 5.483 亿美元。对冲基金持有该股票的 95.62%，显示出强烈的机构兴趣</p>

<p>Teleflex (NYSE:TFX - Get Free Report) was downgraded by research analysts at Wall Street Zen from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a report issued on Saturday.</p>
<div class="lb-trans"><p>泰利福（NYSE:TFX - 获取免费报告）在周六发布的报告中被华尔街 Zen 的研究分析师从 “持有” 评级下调至 “卖出” 评级。</p>
</div><p>A number of other analysts have also recently weighed in on TFX. Raymond James Financial reaffirmed an &#34;outperform&#34; rating and set a $150.00 price objective on shares of Teleflex in a research report on Friday. Weiss Ratings reaffirmed a &#34;sell (d)&#34; rating on shares of Teleflex in a research report on Friday, March 27th. Royal Bank Of Canada raised Teleflex from a &#34;sector perform&#34; rating to an &#34;outperform&#34; rating and increased their price objective for the stock from $135.00 to $155.00 in a research report on Friday. Mizuho set a $140.00 price objective on Teleflex in a research report on Friday. Finally, Bank of America raised Teleflex from an &#34;underperform&#34; rating to a &#34;neutral&#34; rating and set a $135.00 price objective for the company in a research report on Monday, April 13th. Three investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Teleflex currently has an average rating of &#34;Hold&#34; and an average target price of $142.86.</p>
<div class="lb-trans"><p>其他一些分析师最近也对 TFX 发表了看法。雷蒙德·詹姆斯金融公司在周五的研究报告中重申了 “跑赢大盘” 评级，并将泰利福的目标股价设定为 150.00 美元。韦斯评级在 3 月 27 日的研究报告中重申了泰利福的 “卖出（d）” 评级。加拿大皇家银行将泰利福的评级从 “行业表现” 上调至 “跑赢大盘”，并将其目标股价从 135.00 美元提高至 155.00 美元。瑞穗证券在周五为泰利福设定了 140.00 美元的目标股价。最后，美国银行在 4 月 13 日的研究报告中将泰利福的评级从 “表现不佳” 上调至 “中性”，并为该公司设定了 135.00 美元的目标股价。三位投资分析师对该股票给予了买入评级，五位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，泰利福目前的平均评级为 “持有”，平均目标股价为 142.86 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on TFX</strong></p>
<div class="lb-trans"><p><strong>查看我们对 TFX 的最新分析</strong></p>
</div><h2>Teleflex Stock Up 1.1%</h2>
<div class="lb-trans"><h2>泰利福股票上涨 1.1%</h2>
</div><p>Teleflex stock opened at $133.17 on Friday. Teleflex has a twelve month low of $100.18 and a twelve month high of $139.67. The stock has a 50 day moving average of $119.44 and a two-hundred day moving average of $116.73. The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.82. The stock has a market capitalization of $5.89 billion, a price-to-earnings ratio of -5.84, a PEG ratio of 0.95 and a beta of 0.82.</p>
<div class="lb-trans"><p>周五，泰利福股票开盘价为 133.17 美元。泰利福的 12 个月低点为 100.18 美元，12 个月高点为 139.67 美元。该股票的 50 日移动平均线为 119.44 美元，200 日移动平均线为 116.73 美元。公司的流动比率为 2.55，速动比率为 2.01，债务与股本比率为 0.82。该股票的市值为 58.9 亿美元，市盈率为-5.84，PEG 比率为 0.95，贝塔值为 0.82。</p>
</div><p>Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping analysts' consensus estimates of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company had revenue of $548.30 million during the quarter, compared to analysts' expectations of $536.91 million. During the same period last year, the firm earned $1.44 EPS. The firm's revenue for the quarter was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, research analysts expect that Teleflex will post 6.75 earnings per share for the current year.</p>
<div class="lb-trans"><p>泰利福（NYSE:TFX - 获取免费报告）最后一次发布季度财报是在 5 月 7 日，医疗技术公司报告该季度每股收益为 1.39 美元，超出分析师一致预期的 1.21 美元，超出幅度为 0.18 美元。泰利福的股本回报率为 13.29%，净利润率为-35.88%。该公司在该季度的收入为 5.483 亿美元，而分析师预期为 5.3691 亿美元。去年同期，该公司每股收益为 1.44 美元。该公司的季度收入同比增长 32.3%。泰利福已将其 2026 财年的每股收益指引设定为 6.250-6.550 美元。整体来看，研究分析师预计泰利福在当前年度的每股收益将达到 6.75 美元。</p>
</div><h2>Hedge Funds Weigh In On Teleflex</h2>
<div class="lb-trans"><h2>对泰利福的对冲基金看法</h2>
</div><p>A number of large investors have recently modified their holdings of the business. Janus Henderson Group PLC raised its stake in shares of Teleflex by 2.0% during the 4th quarter. Janus Henderson Group PLC now owns 4,246,112 shares of the medical technology company's stock worth $518,196,000 after buying an additional 84,754 shares in the last quarter. AQR Capital Management LLC raised its stake in shares of Teleflex by 478.1% during the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company's stock worth $287,603,000 after buying an additional 1,956,811 shares in the last quarter. State Street Corp raised its stake in shares of Teleflex by 1.5% during the 4th quarter. State Street Corp now owns 1,478,776 shares of the medical technology company's stock worth $180,470,000 after buying an additional 22,111 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Teleflex by 0.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,250,665 shares of the medical technology company's stock worth $152,630,000 after buying an additional 5,051 shares in the last quarter. Finally, Cooke &amp; Bieler LP raised its stake in shares of Teleflex by 1.2% during the 3rd quarter. Cooke &amp; Bieler LP now owns 1,220,637 shares of the medical technology company's stock worth $149,357,000 after buying an additional 14,673 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些大型投资者最近调整了对该公司的持股。Janus Henderson Group PLC 在第四季度将其在泰利福股票中的持股比例提高了 2.0%。Janus Henderson Group PLC 目前拥有 4,246,112 股医疗技术公司的股票，价值 518,196,000 美元，此前在上个季度又购买了 84,754 股。AQR 资本管理公司在第三季度将其在泰利福股票中的持股比例提高了 478.1%。AQR 资本管理公司目前拥有 2,366,131 股医疗技术公司的股票，价值 287,603,000 美元，此前在上个季度又购买了 1,956,811 股。道富银行在第四季度将其在泰利福股票中的持股比例提高了 1.5%。道富银行目前拥有 1,478,776 股医疗技术公司的股票，价值 180,470,000 美元，此前在上个季度又购买了 22,111 股。Dimensional Fund Advisors LP 在第四季度将其在泰利福股票中的持股比例提高了 0.4%。Dimensional Fund Advisors LP 目前拥有 1,250,665 股医疗技术公司的股票，价值 152,630,000 美元，此前在上个季度又购买了 5,051 股。最后，Cooke &amp; Bieler LP 在第三季度将其在泰利福股票中的持股比例提高了 1.2%。Cooke &amp; Bieler LP 目前拥有 1,220,637 股医疗技术公司的股票，价值 149,357,000 美元，此前在上个季度又购买了 14,673 股。95.62% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Key Stories Impacting Teleflex</h2>
<div class="lb-trans"><h2>影响泰利福的关键故事</h2>
</div><p>Here are the key news stories impacting Teleflex this week:</p>
<div class="lb-trans"><p>以下是本周影响泰利福的关键新闻：</p>
</div><ul>
<li>Positive Sentiment: Teleflex beat Q1 estimates, reporting adjusted EPS of $1.39 versus $1.21 expected and revenue of $548.3 million versus $536.9 million expected, which signals solid execution in the quarter. Article Title</li>
<li>Positive Sentiment: The company maintained its full-year 2026 outlook and announced plans for a buyback, which can support investor confidence and share price performance. Article Title</li>
<li>Positive Sentiment: Wells Fargo raised its price target on TFX from $130 to $138, implying modest upside from current levels and suggesting improved analyst sentiment. Article Title</li>
<li>Neutral Sentiment: Management’s earnings call commentary was described as balanced, with growth offset by margin strain, indicating the business is still navigating profitability pressure even after the earnings beat. Article Title</li>
<li>Negative Sentiment: Teleflex’s updated FY2026 EPS guidance of $6.25 to $6.55 came in below the market’s expectation of about $6.73, which could limit enthusiasm despite the quarterly beat. Article Title</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：泰利福超出第一季度预期，报告调整后每股收益为 1.39 美元，而预期为 1.21 美元，收入为 5.483 亿美元，而预期为 5.369 亿美元，显示出该季度的稳健执行。文章标题</li>
<li>积极情绪：该公司维持其 2026 财年的整体展望，并宣布回购计划，这可以支持投资者信心和股价表现。文章标题</li>
<li>积极情绪：富国银行将 TFX 的目标股价从 130 美元上调至 138 美元，暗示当前水平有适度上行空间，并表明分析师情绪改善。文章标题</li>
<li>中性情绪：管理层的财报电话会议评论被描述为平衡，增长被利润率压力抵消，表明尽管财报超出预期，但业务仍在应对盈利压力。文章标题</li>
<li>消极情绪：泰利福更新的 2026 财年每股收益指引为 6.25 至 6.55 美元，低于市场预期的约 6.73 美元，尽管季度业绩超出预期，但可能限制热情。文章标题</li>
</ul>
</div><h2>About Teleflex</h2>
<div class="lb-trans"><h2>关于泰利福</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.</p>
<div class="lb-trans"><p>泰利福公司是一家多元化的全球医疗技术提供商，专注于危重护理和外科手术。公司总部位于宾夕法尼亚州韦恩，设计、制造和分销医疗专业人员在医院、门诊和其他场所使用的设备和解决方案。泰利福专注于提供支持复杂介入程序并改善患者结果的产品。</p>
</div><p>The company's offerings span several key segments, including Interventional Urology, Respiratory &amp; Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.</p>
<div class="lb-trans"><p>公司的产品涵盖多个关键领域，包括介入泌尿学、呼吸与麻醉、外科、心脏护理、血管和原始设备制造商（OEM）解决方案。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Teleflex</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比泰利福更具吸引力</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRGWA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=TFX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Teleflex Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Teleflex 吗？</h2>
</div><p>Before you consider Teleflex, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Teleflex 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛市场注意到之前购买的股票……而 Teleflex 并不在名单上。</p>
</div><p>While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Teleflex 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

泰利福（NYSE: TFX）在华尔街 Zen 的评级被下调至卖出